Related Experiment Video

Updated: Aug 3, 2026

The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants

G Chen1, K A Hasanat, J M Bebchuk

  • 1Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI 48201, USA.

Psychosomatic Medicine
|October 8, 1999
PubMed
Abstract

Insights

Antidepressants and mood stabilizers influence central nervous system gene expression and signaling pathways. This research supports their long-term therapeutic effects by modulating these molecular mechanisms.

Area of Science:

  • Neuroscience
  • Molecular Psychiatry
  • Pharmacology

Background:

  • Mood disorders are complex, with treatment efficacy often linked to long-term molecular changes in the brain.
  • Understanding the mechanisms of action for antidepressants and mood stabilizers is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate evidence supporting the hypothesis that antidepressants and mood stabilizers modulate central nervous system (CNS) signal transduction pathways and gene expression.
  • To investigate the molecular underpinnings of the long-term therapeutic effects of these psychotropic medications.

Main Methods:

  • A comprehensive review of existing scientific literature was conducted.
  • Evidence linking chronic administration of antidepressants and mood stabilizers to alterations in CNS signaling pathways and gene expression was analyzed.

Main Results:

  • Lithium and valproate impact the protein kinase C (PKC) signaling pathway and activator protein 1 (AP-1) transcription factors.
  • Antidepressants modulate the cyclic adenosine monophosphate (cAMP) pathway, potentially mediating therapeutic effects through cAMP-regulated gene expression in the CNS.

Conclusions:

  • The findings highlight the role of specific signaling cascades (PKC, cAMP) in signal integration within the CNS.
  • These molecular insights are vital for advancing research into the etiology and pathophysiology of severe mood disorders.
  • The results provide a foundation for developing novel therapeutic strategies for mood disorders.

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Developing a Rat Model for Bipolar Disorder04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications